ARIXICA is an anticoagulant medication commonly used to help prevent and treat blood clots. It is often prescribed in situations where there is a risk of deep vein thrombosis (DVT), pulmonary embolism (PE), or to reduce the risk of clot formation in certain medical conditions.

Active Ingredient(s) / Generic Name

• Active Ingredient: Fondaparinux sodium

• Strength: 2.5 mg / 5 mg / 7.5 mg / 10 mg (depending on the formulation)

• Generic Name: Fondaparinux

Brand Name / Manufacturer / Marketer
ARIXICA – manufactured and marketed by GlaxoSmithKline (GSK)

Indications / Uses

• Prevention of venous thromboembolism (VTE) after surgery

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Used in patients with certain risk factors for clot formation as advised by a healthcare professional

Storage Instructions
Store ARIXICA in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.

Disclaimer
This information is for general educational purposes and does not replace professional medical advice. Always consult a healthcare professional before using this or any other medication.